![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 2, 2007.
Revised May 29, 2007.
Accepted for publication May 30, 2007.
We determined the functional role of a small domain in the third intracellular loop of the human muscarinic M1 (hM1) receptor. Using site-directed mutagenesis, several mutant hM1 receptors were made possessing either a deletion or point mutations within the third intracellular loop domain 252-PETPPGRCCRCC-263. Wild-type and mutant hM1 receptors were transiently expressed in CHO cells and the effects of each mutation on radioligand binding, agonist-mediated phosphoinositide hydrolysis, and agonist-induced internalization were determined. The mutant receptors exhibited a modest reduction in affinity for [3H]N-methylscopolamine (pKD = ~9.0) and a moderately increased binding capacity relative to the wild-type receptor (pKD = 9.57 ± 0.07). This moderate increase in binding capacity was associated with small increases in the maximal response and potency of carbachol for eliciting phosphoinositide hydrolysis through the mutant receptors (pEC50 = ~5.5) relative to wild-type (pEC50 = 5.35 ± 0.05). In contrast, carbachol-induced internalization of mutant hM1 receptors possessing either CC259-260AA or CC262-263AA, or both, double point mutations was significantly reduced when compared to the wild-type hM1 receptor. Of the hM1 receptor mutants tested, those possessing a CC262-263AA double point mutation had the least extensive carbachol-induced internalization. The desensitization and downregulation of receptors possessing this Cys/Ala double point mutation was similar to that observed for the wild-type hM1 receptor. Collectively, these observations suggest that Cys pairs 259-CC-260 and 262-CC-263 play an important role in the agonist-induced internalization of hM1 receptors.
Key words:
Cysteines, Desensitization, Internalization, Muscarinic, Mutagenesis, Receptors